Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:16:43 EDT Fri 18 Jul 2025
Enter Symbol
or Name
USA
CA



Q:ANIP - ANI PHARMACEUTICALS INC - https://www.anipharmaceuticals.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ANIP - Q7.061.50·69.500.866.30-1.74-2.6326.221,4694,94068.44  68.60  66.2076.9999  52.5016:33:02Jul 0215 min RT 2¢

Recent Trades - Last 10 of 4940
Time ETExPriceChangeVolume
16:33:02Q66.30-1.741,122
16:20:00Q66.30-1.74487
16:04:12Q66.30-1.741
16:04:08Q66.30-1.741
16:04:01Q66.30-1.741
16:01:31Q66.30-1.746
16:01:07Q66.30-1.74134
16:00:44Q66.30-1.74221
16:00:08Q66.30-1.74666
16:00:08Q66.30-1.74265

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-07-02 06:50U:ANIPNews ReleaseANI Pharmaceuticals to Participate at Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8th
2025-06-12 07:00U:ANIPNews ReleaseANI Pharmaceuticals Announces Presentation of New Preclinical Data
2025-05-27 16:30U:ANIPNews ReleaseANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
2025-05-22 06:50U:ANIPNews ReleaseANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin(TM) Gel for the Treatment of Acute Gout Flares
2025-05-12 18:30U:ANIPNews ReleaseANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ
2025-05-09 07:24U:ANIPSEDAR Interim MD & ASEDAR Interim MD & A
2025-05-09 07:19U:ANIPSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-05-09 06:50U:ANIPNews ReleaseANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance
2025-05-05 07:00U:ANIPNews ReleaseANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin(TM) Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model
2025-04-09 06:50U:ANIPNews ReleaseANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET
2025-03-31 16:30U:ANIPNews ReleaseANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference
2025-03-19 06:50U:ANIPNews ReleaseANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets
2025-03-18 06:50U:ANIPNews ReleaseANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN(TM) and YUTIQ(TM)
2025-03-14 06:50U:ANIPNews ReleaseANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN(TM) Label
2025-03-03 16:30U:ANIPNews ReleaseANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel(TM) Prefilled Syringe
2025-02-28 07:57U:ANIPSEDAR MD & ASEDAR MD & A
2025-02-28 07:51U:ANIPSEDAR Annual ReportSEDAR Annual Report
2025-02-28 07:46U:ANIPSEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-02-28 06:50U:ANIPNews ReleaseANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance
2025-02-19 16:30U:ANIPNews ReleaseANI Pharmaceuticals to Present at Raymond James' Institutional Investors and Leerink Partners Global Healthcare Conferences in March